Cho et al . [ 21 ] |
22 RA ( 100 %)
20 Controls ( 100 %)
|
Intervention group
Age : 49 ( 12 )
• Disease duration : 8 ( 6 )
• Control group
• Age : 49 ( 12 )
• Disease duration : 7 ( 7 )
|
24 Extra-depth shoes + custom orthoses
• Wide toe box , cushioned heel , forefoot rocker
• Custom orthoses : medial arch support , medial heelpost , metatarsal pad
|
Extra-depth shoes + prefabricated insoles
• Wide toe box , cushioned heel , forefoot rocker
• Prefabricated insole ; 6mm Plastazote
|
Primary outcomes
• Foot pain ( VAS )
• Foot pain , disability , activity limitation ( FFI )
|
Between group measures :
• No significant differences in foot pain and FFI total
Scores between intervention and control group at follow-up .
Within group measures
|
61 % |
• Significant reduction in foot pain ( p o 0.05 ) in intervention and control groups at follow-up . |
|||||||
Menz et al . [ 12 ] |
• 46 1MTPJ OA ( 61 %)
• 52 Controls ( 44 %)
|
• Intervention group
• Age : 57 ( 11 )
• Median disease duration : 2
• Control group
• Age : 57 ( 11 )
• Median Disease duration : 3
|
12 • Rocker-sole footwear
• ( Masai Barefoot Technology ( MBT ) Mahuta / Matwa )
• Rounded sole , soft cushioned heel
|
• Own footwear + orthoses
• VasyliCustoms
• Full length , cut out under1st metatarsal , varus wedge ( FPI > 7 )
|
Primary outcome
Foot pain ( FHSQ )
Outcomes assessed
Function ( FHSQ ) Foot pain , stiffness , difficulty , activity limitation , social issues ( FFI-RSF ) 1MTP walkpain , 1MTP restpain , 1MTP stiffness ( VAS )
|
Between group measures
• No significant differences in foot pain , function , stiffness , difficulty , activity limitation , social issues , MTP pain and MTP stiffness between group sat follow-up .
Within group measures
• Not reported
|
96 % |